Disclosure Of Entity's Operating Segments [Text Block]

ERYTECH Pharma S.A. - Filing #2810992

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Tax expense (income)
208,000 EUR
521,000 EUR
2,000 EUR
Profit (loss)
23 488 EUR
23 488 EUR
228,000 EUR
228,000 EUR
53 797 EUR
53 797 EUR
Assets
51 307 EUR
45 811 EUR
66 768 EUR
Cash flows from (used in) operating activities
24 428 EUR
31 763 EUR
56 770 EUR
Cash flows from (used in) investing activities
171,000 EUR
38 126 EUR
345,000 EUR
Cash flows from (used in) financing activities
3 716 EUR
1 768 EUR
44 712 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.